|
Revascularization
Citations 81-90 of 246 total displayed.
|
Past content
(since Jun 1998):
|
- Original Contributions
Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction
- Judith S. Hochman; Lynn A. Sleeper; John G. Webb; Vladimir Dzavik; Christopher E. Buller; Philip Aylward; Jacques Col; Harvey D. White; for the SHOCK Investigators
JAMA 2006; 295: 2511-2515.
[Abstract]
[Full text]
[PDF]
- JAMA Patient Page
Cardiogenic Shock
- Erin Brender; Cassio Lynm; Richard M. Glass
JAMA 2006; 295: 2566.
[Extract]
[Full text]
[PDF]
[ Spanish PDF ]
- Original Contributions
Certificate of Need Regulations and Use of Coronary Revascularization After Acute Myocardial Infarction
- Ioana Popescu; Mary S. Vaughan-Sarrazin; Gary E. Rosenthal
JAMA 2006; 295: 2141-2147.
[Abstract]
[Full text]
[PDF]
- Editorials
Evaluating and Improving the Quality of Care for Acute Myocardial Infarction: Can Regionalization Help?
- Edward L. Hannan
JAMA 2006; 295: 2177-2179.
[Extract]
[Full text]
[PDF]
- Letters
Efficacy and Safety of Edifoligide
- George T. Lau; Leonard Kritharides
JAMA 2006; 295: 1513-a-1514-a.
[Extract]
[Full text]
[PDF]
- Letters
Efficacy and Safety of Edifoligide
- Alessandro Parolari; Francesco Alamanni; Elena Tremoli; Paolo Biglioli
JAMA 2006; 295: 1513.
[Extract]
[Full text]
[PDF]
- Letters
Efficacy and Safety of Edifoligide—Reply
- John H. Alexander; Robert A. Harrington; T. Bruce Ferguson; Eric D. Peterson; C. Michael Gibson; Nicholas T. Kouchoukos; for the PREVENT IV Investigators
JAMA 2006; 295: 1514-a-1515-a.
[Extract]
[Full text]
[PDF]
- Letters
Efficacy and Safety of Edifoligide
- Nimesh D. Desai; Stephen E. Fremes
JAMA 2006; 295: 1514.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial
- The OASIS-6 Trial Group*
JAMA 2006; 295: 1519-1530.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial
- Adnan Kastrati; Julinda Mehilli; Franz-Josef Neumann; Franz Dotzer; Jurriën ten Berg; Hildegard Bollwein; Isolde Graf; Maryam Ibrahim; Jürgen Pache; Melchior Seyfarth; Helmut Schühlen; Josef Dirschinger; Peter B. Berger; Albert Schömig; for the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators
JAMA 2006; 295: 1531-1538.
[Abstract]
[Full text]
[PDF]
|
|
